Ensign Peak Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1M | Sell |
|
|||||
|
2025
Q2 | $1.38M | Hold |
|
|||||
|
2025
Q1 | $969K | Hold |
|
|||||
|
2024
Q4 | $1.12M | Hold |
|
|||||
|
2024
Q3 | $1.34M | Hold |
|
|||||
|
2024
Q2 | $1.54M | Hold |
|
|||||
|
2024
Q1 | $1.94M | Sell |
|
|||||
|
2023
Q4 | $1.87M | Hold |
|
|||||
|
2023
Q3 | $1.36M | Hold |
|
|||||
|
2023
Q2 | $1.68M | Buy |
|
|||||
|
2023
Q1 | $1.25M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $2.26M | Buy |
|